Switch theme
Sign up to access all valuation multiples
HK Inno N Corp manufactures pharmaceutical products.
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
HK inno.N has a last 12-month revenue (LTM) of $688M and a last 12-month EBITDA of $103M.
In the most recent fiscal year, HK inno.N achieved revenue of $652M and an EBITDA of $91.7M.
HK inno.N expects next 12-month revenue of XXX and NTM EBITDA of XXX
See HK inno.N valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $688M | XXX | $652M | XXX | XXX | XXX |
| Gross Profit | $332M | XXX | $316M | XXX | XXX | XXX |
| Gross Margin | 48% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | $103M | XXX | $91.7M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBIT | $68.7M | XXX | $64.1M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $47.4M | XXX | $44.8M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $272M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, HK inno.N's stock price is KRW 41700 (or $30).
HK inno.N has current market cap of KRW 1.18T (or $859M), and EV of KRW 1.54T (or $1.1B).
See HK inno.N trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $859M | XXX | XXX | XXX | XXX | $1.68 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, HK inno.N has market cap of $859M and EV of $1.1B.
HK inno.N's trades at 1.7x EV/Revenue multiple, and 12.2x EV/EBITDA.
Equity research analysts estimate HK inno.N's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
HK inno.N has a P/E ratio of 18.1x.
See valuation multiples for HK inno.N and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $859M | XXX | $859M | XXX | XXX | XXX |
| EV (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 10.9x | XXX | 12.2x | XXX | XXX | XXX |
| EV/EBIT | 16.3x | XXX | 17.4x | XXX | XXX | XXX |
| EV/Gross Profit | 3.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 18.1x | XXX | 19.2x | XXX | XXX | XXX |
| EV/FCF | 52.2x | XXX | -77.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHK inno.N's last 12 month revenue growth is 10%
HK inno.N's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
HK inno.N's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
HK inno.N's rule of X is 41% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for HK inno.N and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 23% | XXX | XXX | XXX |
| Rule of 40 | 23% | XXX | 25% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 41% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 39% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
HK inno.N acquired XXX companies to date.
Last acquisition by HK inno.N was XXXXXXXX, XXXXX XXXXX XXXXXX . HK inno.N acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| Where is HK inno.N headquartered? | HK inno.N is headquartered in South Korea. |
| Who is the CEO of HK inno.N? | HK inno.N's CEO is Mr. Dal-Won Kwak. |
| Is HK inno.N publicy listed? | Yes, HK inno.N is a public company listed on KRX. |
| What is the stock symbol of HK inno.N? | HK inno.N trades under 195940 ticker. |
| When did HK inno.N go public? | HK inno.N went public in 2021. |
| Who are competitors of HK inno.N? | Similar companies to HK inno.N include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of HK inno.N? | HK inno.N's current market cap is $859M |
| What is the current revenue of HK inno.N? | HK inno.N's last 12 months revenue is $688M. |
| What is the current revenue growth of HK inno.N? | HK inno.N revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of HK inno.N? | Current revenue multiple of HK inno.N is 1.6x. |
| Is HK inno.N profitable? | Yes, HK inno.N is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of HK inno.N? | HK inno.N's last 12 months EBITDA is $103M. |
| What is HK inno.N's EBITDA margin? | HK inno.N's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of HK inno.N? | Current EBITDA multiple of HK inno.N is 10.9x. |
| What is the current FCF of HK inno.N? | HK inno.N's last 12 months FCF is $21.4M. |
| What is HK inno.N's FCF margin? | HK inno.N's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of HK inno.N? | Current FCF multiple of HK inno.N is 52.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
